Structure-based screening of marine carotenoids: fucoxanthin and its derivatives as potential inhibitors of the SARS-CoV-2 nucleocapsid phosphoprotein.

Documenti analoghi

• SARS‐CoV‐2 nucleocapsid antigen in plasma of children hospitalized for COVID‐19 or with incidental detection of SARS‐CoV‐2 infection
  di: Nicolas Capelli, et al.
  Pubblicazione: (2024)
• A peptide derived from SARS‐CoV‐2 nucleocapsid protein with broad‐spectrum anti‐coronavirus activity
  di: Guoguo Ye, et al.
  Pubblicazione: (2024)
• SARS ‐ CoV ‐2 nucleocapsid protein variants have differential RNA chaperone activity
  di: Sabrina Babl, et al.
  Pubblicazione: (2025)
• An exhaustive computational bioassessment of plant‐derived terpenoids as potential SARS‐CoV‐2 inhibitors
  di: Arunkumar Radhakrishnan, et al.
  Pubblicazione: (2026)
• Ensemble docking based virtual screening of SARS‐CoV‐2 main protease inhibitors
  di: Anastasia D. Fomina, et al.
  Pubblicazione: (2024)